Bausch Health Cos Total Assets 2012-2026 | BHC
Bausch Health Cos total assets from 2012 to 2026. Total assets can be defined as the sum of all assets on a company's balance sheet.
|
Bausch Health Cos Annual Total Assets (Millions of US $) |
|
|---|---|
| 2025 | $26,366 |
| 2024 | $26,523 |
| 2023 | $27,350 |
| 2022 | $25,686 |
| 2021 | $29,202 |
| 2020 | $31,199 |
| 2019 | $33,863 |
| 2018 | $32,492 |
| 2017 | $37,497 |
| 2016 | $43,529 |
| 2015 | $48,965 |
| 2014 | $26,305 |
| 2013 | $27,971 |
| 2012 | $17,950 |
| 2011 | $13,108 |
|
Bausch Health Cos Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2026-03-31 | $24,498 |
| 2025-12-31 | $26,366 |
| 2025-09-30 | $26,824 |
| 2025-06-30 | $27,266 |
| 2025-03-31 | $26,421 |
| 2024-12-31 | $26,523 |
| 2024-09-30 | $26,540 |
| 2024-06-30 | $26,495 |
| 2024-03-31 | $26,913 |
| 2023-12-31 | $27,350 |
| 2023-09-30 | $27,064 |
| 2023-06-30 | $25,503 |
| 2023-03-31 | $25,445 |
| 2022-12-31 | $25,686 |
| 2022-09-30 | $26,298 |
| 2022-06-30 | $28,171 |
| 2022-03-31 | $29,090 |
| 2021-12-31 | $29,202 |
| 2021-09-30 | $29,252 |
| 2021-06-30 | $30,042 |
| 2021-03-31 | $30,197 |
| 2020-12-31 | $31,199 |
| 2020-09-30 | $31,562 |
| 2020-06-30 | $31,396 |
| 2020-03-31 | $31,865 |
| 2019-12-31 | $33,863 |
| 2019-09-30 | $31,667 |
| 2019-06-30 | $32,354 |
| 2019-03-31 | $32,551 |
| 2018-12-31 | $32,492 |
| 2018-09-30 | $33,777 |
| 2018-06-30 | $34,448 |
| 2018-03-31 | $35,798 |
| 2017-12-31 | $37,497 |
| 2017-09-30 | $39,974 |
| 2017-06-30 | $41,733 |
| 2017-03-31 | $42,333 |
| 2016-12-31 | $43,529 |
| 2016-09-30 | $45,761 |
| 2016-06-30 | $47,662 |
| 2016-03-31 | $49,020 |
| 2015-12-31 | $48,965 |
| 2015-09-30 | $48,455 |
| 2015-06-30 | $48,343 |
| 2015-03-31 | $38,566 |
| 2014-12-31 | $26,305 |
| 2014-09-30 | $27,060 |
| 2014-06-30 | $27,896 |
| 2014-03-31 | $27,989 |
| 2013-12-31 | $27,971 |
| 2013-09-30 | $28,204 |
| 2013-06-30 | $19,782 |
| 2013-03-31 | $17,486 |
| 2012-12-31 | $17,950 |
| 2012-09-30 | $14,146 |
| 2012-06-30 | $14,020 |
| 2012-03-31 | $13,620 |
| 2011-12-31 | $13,108 |
| 2011-09-30 | $11,818 |
| 2011-06-30 | $11,828 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.086B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |